第四届中美临床和转化医学国际论坛

会 议 日 程  

(May 25 version)

6月21日(星期五) 报到 (Registration)

会前会交流活动  (Pre-Conference Meeting hosted by《Translational Medicine Journal》):

15:00-17:30：        专家座谈《转化医学杂志》主编主持: 中美临床和转化医学国际合作 -“走出去”计划

                                交流访问和考察NIH临床中心、耶鲁大学转化中心以及杜克大学临床研究中心的体会

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------6月22日              Opening Ceremony by co-chairs

(8:15-8:30):             开幕式: 中美国际论坛共同主席致词

        全球医生组织和中华医学国际交流基金会：公布建立“中美临床和转化医学基金”专项 合作

Clinical and Translational Medicine Fund: “Physician-Scientists Awards” by Global MD and CMAIF

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

大会主题1：      临床和转化医学国际协作：更好的交流，带来更丰硕的成果

共同主席:           Co-chairs: Dr. DAI Jianping and Dr. Barbara Alving

8:30-8:55                 演讲1: 从政府科研经费资助到民间基金支持, 如何引导建设临床和转化医学研究前沿领域         

                                戴建平教授, 中华医学国际交流基金会理事长, 中华医学会副会长

                                From Government Grants to Private Fund: the Landscape Changing to Support Clinical and Translational Research

Dr. DAI Jianping, Vice Chairman of Chinese Medical Association, Director for Chinese Medical Association Foundation for International Exchange Program, the Member of Institute of Medicine (IOM), the U.S.

8:55-9:20                 演讲2: 美国NIH资助建立60家转化医学研究院, 解决了什么问题?  未来5年的发展趋势

                             Dr. Barbara Alving教授, NIH NCRR前主任, CTSA负责人, 马里兰大学转化科学策略办公室, 负责人

                                NIH-CTSA funded 60 CTSI, What are the problems be solved? What are the Trends in CTS within next 5 Years?

                                Dr. Barbara Alving, formerly NIH NCRR Director, in Charge of CTSA Program, now at Univ. of Maryland CTSI

9:20-9:45                 演讲3: 企业关注转化研究产出、市场竞争和临床有效性: 肿瘤药物转化研究策略与方法

彭斌博士, 诺华制药抗肿瘤药物研发和转化医学中心资深总监

Industrial Partner Focusing on Outcomes, Marketing Competition and Efficiency: Clinical and Translational

Research Strategy, and Methodology on Oncology

Dr. PENG Bin, Director of Novartis Cancer Drug Translational Science Center, Shanghai, China

9:45-10:15             主题论坛一: 转化医学国际协作的渠道与当前的障碍 (上述报告人 + 主持人)

   主持人: 曾益新教授,北京协和医科大学校长

   Dr. York Tomita, 美国FDA局长办公室首席科学家及关键路径与创新资深顾问

       Panel 1: Advancing International Collaboration on Translational Research: Identified Obstacles and Solutions

       Moderators: Dr. ZENG Yixin, Dean of Beijing Union Medical College, VP of Chinese Academy of Medical Sciences

                             Dr. York Tomita, Sr. Advisor for FDA Commissioner Office and Critical Path and Innovation Office

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

10:15-10:30             茶歇 (Tea/Café Break)

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

大会主题2：     中美临床和转化医学中心：建立更有效的国内和国际合作机制

共同主席:           Co-chairs: Dr. FU Xiaobin and Dr. Greg Koski

10:30-10:55             演讲4: 范德堡大学的经验: 培养多学科交叉合作能力，建立非竞争性有效机制

                                Dr. David Robertson, 范德堡大学临床试验中心主任；《临床和转化医学概论: 人体研究原则》主编

                                Vanderbilt''''''''''''''''''''''''''''''''s Experience: Innovation and multidiscipline in Translational Research and Non-Competitive Mechanism 

                                Dr. David Robertson, Director of the Clinical Research Center at the Vanderbilt University

11:55-11:20             演讲5: 临床和转化医学实践的规范与准则 – 探讨研究型医院开展临床和转化研究的实践

付小兵教授, 中国人民解放军总医院基础医学研究院，建立第一家转化研究试验病房

                                Chinese Research-oriented Hospital: Practice and Experience of Clinical and Translational Research

Dr. FU Xiaobing, Director for Institute of Basic Medical Research, Chinese PLA General Hospital

11:20-11:45             演讲6: 培养研究型临床医生 – 如何将临床教育与实践结合到临床转化研究中去

                                Dr. Greg Koski, 美国药师和医学研究学会主席，哈佛大学医学院、麻省总医院教授

                                Career Path Development and Training for Physician-Scientists: Alignment of Competencies for

                                Inter-Professional Education in Clinical and Translational Research

                                Dr. Greg Koski, Massachusetts General Hospital, President of the Society of Pharmacology and Medical Research

11:45-12:10             演讲7: 培养研究型临床医生 – 专科临床医生的职业规划和在职教育模式的拓展

                           , ;     陆军教授, 中国医师协会副会长; 柳琪林博士,中国医师协会培训部主任

                               Training Physician-Scientist: Career Development for Clinical Specialist and Education Model Changing

                                Ms. LU Jun, Vice Chairman for Chinese Physician Association,

                                Dr. LIU Qilin, Director for Training Division at Chinese Physician Association

12:10-12:30             主题论坛二：共享成功经验与方法 (上述报告人 +  主持人)

                                主持人: 钟南山教授,  广州中山医学呼吸系统疾病研究所所长

                                Dr. Anantha Shekhar, 美国临床和转化科学协会主席, 美国印地安那大学临床和转化研究院院长

                                Moderators: Dr. ZHONG Nanshan, Director for Guangzhou Institute of Respiratory Diseases.

                                                      Dr. Anantha Shekhar, Chairman for the USA Clinical and Translational Association,

                                                  Sr. Associate Dean & Director of Clinical and Translational Science Institute, University of Indiana

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

12:45-13:45               午餐 / 特邀交流活动 (Lunch Special Event/meeting):

编委会会议：        主持人:《转化医学杂志》钱阳明主编, 讨论中美转化医学领域期刊合作和论文发表规范

Editors board meeting: 《Translational Medicine》 Editor-in-Chief, Dr. QIAN Yangming, President of Navy General Hospital

(Invitation ONLY)            Collaboration in Journals of Translational Medicine and Publication Policies

新书发布会:            主持人: 王吉耀教授、刘晓清教授、王睿教授、以及科学出版社负责人

                                   美国NIH《临床研究规范和准则》第3版新书发布，以及导读《临床研究规范和准则》

News book release: NIH Principles and Practice of Clinical Research, the 3^rd ed Chinese Version, Reading and Commentary

Moderators:              Co-Translators and Chief-Editor: Dr. WANG Jiyao, Dr. LIU Xiaoqing, Dr. WANG Rui and Dr. Yang Xiaoling

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

6月22日下午：                   专 题 分 会 及 分 论 坛 (14:00 - 17:30)

肿瘤疾病临床与转化研究:肿瘤的基础、临床与转化医学的优先研究课题

Clinical and Translational Research in Oncology: The Priority Subjects of Basic, Clinical and Translational Studies

共同主席:    Dr. Vicki Seyfert-Margolis, FDA局长前首席科学家

Co-Chairs:      Dr. PENG Bin, 诺华抗肿瘤药物临床研发和转化中心资深总监

        吴开春教授,第四军医大学西京消化病医院常务副院长

1) 肺癌的临床与转化研究                         Chou Chai Chun教授

2) 肺癌生物标记物 (Lung Cancer Biomarker)            张旭超教授, 广东省肺癌研究所所长

3) 肝癌的临床和转化研究                         秦叔逵教授, 南京军区总院副院长

4) 鼻咽癌治疗与转化研究进展                   张力教授, 中山大学附属肿瘤医院

5) 消化道肿瘤的转化研究                         吴开春教授, 西京消化病医院常务副院长

6) 肿瘤的临床试验规范与准则                   石远凯教授, 中国医学科学院肿瘤医院副院长

7)  肿瘤生物标记物-应用策略和方法     &nbs, p;      Dr. Yao Yao, 诺华抗肿瘤药物临床研发和转化中心

8)   FDA生物标记物(Biomarker)认证项目和规则            Dr. Vicki Seyfert-Margolis, FDA局长前首席科学家

9)  考察肿瘤药物的现状与瓶颈问题                       高晨燕副部长, CFDA-CDE肿瘤药物审评专家

10)  探讨肿瘤的细胞治疗和临床试验规范准则              张树人教授, 中国医学科学院肿瘤医院免疫室主任

11)   DNA methylation based cancer diagnostics: opportunities and challenges, 朱景德教授、上海交大肿瘤研究所

12)   ADADT treatment targeting colorectal cancer stem cells-A translational model, Dr. Edward Lin、上海生命科学研究院

13)    Mayo Clinic Cancer Center: Translational Research Practice, Dr. Robert Diasio, Director of Mayo Clinic Cancer Center

14)    Swedish Cancer Institute /Providence Cancer Center, Dr. Thomas Brown, President of Swedish Cancer Institute (SCI)

15)    Building up an Int’l Cancer Center and Translational Systems Between US and China, Dr. Qiang Tian、上海生命科学研究院

干细胞临床研究规范与准则:干细胞 临 床 和 转 化 研 究 标 准 和 规 范        

Stem Cell Clinical Therapeutic Research: Principles and Consensuses of Clinical and Translational Studies

共同主席:     吴祖泽院士, 军事医学科学院，Dr. WU Zuze, Chinese Military Academy of Medical Sciences

Co-chairs: Dr. Curt Civin, 马里兰大学医学院常务副院长，干细胞临床研究中心主任

           Dr. Curt Civin,   Sr. Associate Dean of Univ. of Maryland School of Medicine, Director for Stem Cell Research

·               韩忠朝院士, 国家干细胞工程技术研究中心主任、华夏干细胞产业技术联盟理事长

·               Dr. Sandra Alfano , 耶鲁大学胚胎干细胞临床研究监管委员会联合主席,

Chair for Yale Univ. Embryonic Stem Cell Research Inspection Committee

·               题目:TBD       曾凡一教授，上海交通大学医学院，遗传疾病研究所副所长                 

·               题目:TBD       中国医学科学院干细胞研究中心           Stem Cell Research Center, CAMS

·               题目:TBD      中国人民解放军总医院老年疾病研究所  Aging Disease Research Center, PLA General Hospital

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

分论坛 A        临床和转化医学中心建设经验共享

(14:00-17:00)     共同主席: 张抒杨教授,北京协和医院副院长,Dr. ZHANG Shuyang, VP of Beijing Union Hospital

                                              Ms. Tesheia Johnson, Chief Operation Officer, Yale Center for Clinical Investigation, Yale Univ.

1.    耶鲁大学GCRC药物临床试验中心与北京协和医院GCP国家药物临床试验机构模式对比

      Dr. ZHANG Shuyang, Vice President of Beijing Union Hospital and Director of PUMC Hospital GCP Center

     Dr. Richard Bucala, Director for Epidemiology and Pathology, in charge of early phase drug trial studies, Yale University

2.    中国以医院为核心的转化医学研究中心: 顶层设计理念，以及与国际规范化接轨的实践

      李宁教授，首都医科大学附属北京佑安医院院长

      Chinese Hospital-based Translational Research Center: Top Design and Practice with the International HRP Standards

      Dr. LI Ning, President of Beijing YouAn Hospital, Beijing Capital Medical University

3.    医院GCP 机构模式:药物试验与产业合作伙伴

     袁洪教授, 中南大学湘雅三院副院长，国家药物临床试验中心主任

     Hospital-GCP Center：Collaboration with Industrial Partner to Advancing Drug Clinical Trials

      Dr. YUAN Hong, Vice President of the 3^rd Xiangya Hospital, China Central South University

4.    加速药物临床和转化试验成功的多学科综合能力

Dr. Satish R. Raj, Director for Division of Cardiology & Clinical Pharmacology, Vanderbilt University

5.    技术成果转化中心：建立和促进科研项目转化和成果展示

龚启勇教授，华西医院副院长

Technology and Innovation Transferring Center at West China Hospital: Advancing Research Outcomes and Demoninstration

Dr. GONG Qiyong, Vice President of West China Hospital

6.    按照国际规范建立临床研究和创新技术中心-心血管疾病和医疗器械的转化研究

      马长生教授，首都医科大学附属北京安贞医院

Aligned with International Standards to build up Clinical Research and Innovation Center: Focusing on Improvement of Cardiovascular Diseases Therapeutics and Medical Devices

     Dr. MA Changsheng, Beijing Anzhen Hospital, Beijing Capital Medical University

7.    问答及互动交流 （Q & A）

--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------分论坛B         国际合作战略伙伴和模式: 中美医学院校对接临床和转化医学领域

(14:00-17:00)    共同主席:  桂永浩院长,上海复旦大学医学院, Dr. GUI Yonghao, Dean of Shanghai Med. College, Fudan Univ.

 　                                          Dr. Joseph Kolars, 密西根大学临床和转化科学研究院院长Sr. Associate Dean for Univ of Michigan

1.    哈佛 CTSI 和中国合作伙伴(中国医学科学院、上海交通大学，复旦大学上海医学院)

      桂永浩副校长，上海复旦大学医学院院长

      Harvard CTSI – Chinese Academic Partners on Translational Sciences：Goals and Vision

      Dr. GUI Yonghao, Vice Chancellor and Dean of Shanghai Medical College, Shanghai Fudan University

2.    密歇根大学和中国合作伙伴(北京大学医学部)

      Dr. Joseph Kolars, 密西根大学临床和转化科学研究院院长

      Peking University Medical Center and Univ. of Michigan CTSI Strategic Partnership and Experience

     Dr. Joseph Kolars, Director of UM CTSI and Sr. Associate Dean for Univ. of Michigan School of Medicine

3.    杜克大学转化科学中心：杜克大学在中国建立第一个临床试验教育基地(江苏昆山)

Duke Univ. Kunshan Campus: the first Independent Clinical Research and Training Site in China

Robert Califf, Vice Chancellor of clinical and translational research, Duke Univ. Director for Duke CTSI

4.    中山大学医学院:美国霍普金斯大学医学院共建临床和转化医学研究中心

      黎孟枫院长, 中山大学附属中山医学院,

      Zhongshan Univ. School of Medicine: Joint collaborations with the Johns Hopkins Univ. School of Medicine CTSI

      Dr. LI Mengfeng, Dean of Zhongshan Medical College, Zhongshan University

5.    上海儿童疾病临床研究中心转化医学中心模式与发展：针对儿童罕见疑难疾病

      Director for Shanghai Jiaotong Univ. Children Disease Clinical and Translational Research Center:

      Model and Development focusing on children rare and unknown diseases.

6.    建立全国性的转化医学协作项目Developing a Statewide Translational Research Program

      Dr. Anantha Shekhar, 美国临床和转化科学协会主席, 美国印地安那大学临床和转化研究院院长

      Dr. Anantha Shekhar, Chairman for the Association of Clinical and Translational Sciences             

      Sr. Associate Dean & Director of Clinical and Translational Science Institute, University of Indiana

7.    问答及互动交流 （Q & A）

---------------------------------------------------------------------------------------------------------------------------------------------------------------

 (14:00-17:00)  共同主席:  冯毅主任助理, 国家食品药品监督管理总局药物审评中心 (CFDA-CDE)

       Dr. York Tomita, Sr. Advisor for FDA Commissioner Office and Critical Path and Innovation Office

1.    CFDA 推进 IND 机制与中国新药创新临床试验的瓶颈问题   

      冯毅主任助理，国家食品药品监督管理总局药物审评中心

      CFDA advancing the IND Mechanism and Encourage Translational Research: Bottle-neck with New Drug Innovation

      Dr. FENG Yi, CFDA Center for Drug Evaluation

2.    FDA 助力转化医学领域发展：促进罕见疾病和个体化治疗

      Dr. York Tomita, Sr. Advisor for FDA Commissioner Office and Critical Path and Innovation Office

     FDA Critical Path and Innovation: Accelerate Translational Research: Rare and Personalized Medicine

3.    制药企业与医院GCP机构合作：提高临床试验管理规范和政策法规

      夏明德总监，杨森制药国际合作部总监

      Industrial partner with Hospital GCP centers: Improvement of Clinical Trial Management and Regulatory Sciences

      Dr. XIA Mingde, Director for International Collaboration, Johnsons & Johnson Pharmaceutical (China)

4.    北京重大疾病临床信息库与样本库建设探索与实践

王彭主任,首都医科大学生物样本库

Beijing Biobank and medical informatics: Infrastructure and Practice

Dr. WANG Peng, Director of Beijing Capital Medical University BioBank Project

5.    ISBER国际生物样本库认证标准和指南建议:药物创新和转化的资源

Speaker: TBD

6.    遗传药物学的临床与转化研究实践与体会

     陈小平教授，中南大学临床药理研究所

      Pharmacogenetics and Translational Research Experiences in Patient trial studies

      Dr. CHEN Xiaoping, Director of Institute of Clinical Pharmacology, China Southern University

7.    中国脑血管疾病(Stroke)的转化医学研究和预期产出

     王拥军教授，天坛医院副院长

      Chinese Stroke Diseases and Preventions: Translational Research and Outcome Perspectives

     Dr. WANG Yongjun, Vice President of Tiantian Hospital

8.    互动交流

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

分论坛D         培养研究型临床医生－科学家：临床和转化医学专业培训和职业发展规划

(14:00-17:00)    共同主席:  王发强会长, 中国研究型医院学会

                                              Dr. Honorio Silva, President of the Inter American Foundation for Clinical Research

1.     培养临床和转化医学专家实践：建立国际认证的临床研究型医生和临床研究护士培训机制

      Dr. Honorio Silva, President of the Inter American Foundation for Clinical Research

      Discussion the possibility to formalize the training mechanism and components for Clinical Researchers and Nurses

2.     研究型医院：定位于促进临床和转化医学，开展科研协作，促进医疗诊疗服务质量

      王发强会长, 中国研究型医院学会

      Research-oriented Hospital: Promote Translational Research Practice, Aims to improve the quality of healthcare service

      Dr. WANG Faqiang, Chairman of Chinese Society for Research-Oriented Hospitals

3.     耶鲁大学临床研究院：注重教育模式和导师职责的转化医学研究院

      Dr. Patrick O’Connor, Chief Internal and General Medicine, Training Program at Yale University

Yale University YCCI: Focusing on Training and Education through building up the multidisciplinary mentorship

4.     University of Michigan CTSI临床研究中心: 我们应该为年轻医师做些什么？

      Dr. Amy Huang, International Director for Dean Office at University of Michigan CTSI

      University of Michigan CTSI: What should we do for young physicians during their career development

5.     TBD (北京大学医学部，speaker TBD待确定)

6.     TBD (军事医学科学院，speaker TBD待确定)

7.     问答及互动交流 （Q & A）

 ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

分论坛E         以患者为核心的转化研究项目与医疗实践：临床研究方法和创新研发工具

(14:00-17:00):    共同主席: Dr.Paul Watkins, 美国药物引起肝毒损伤协作网机构, NIH资助项目

                        贾继东教授, 首都医科大学附属友谊医院传染科主任

1.     对比中美在药物研发（感染性药物临床试验）中的临床评审规范与实践“走出去，看一看”

      王涛博士, 国家食品药品监督管理总局药物审评中心，临床审评I部部长

      Dr. WANG Tao, Director of Division I at Center for Drug Evaluation (CDE), China FDA

2.     对比临床医师与基础科研人员之间的研究工作：如何提炼临床研究问题

     刘晓清教授, 北京协和医院感染科主任

      Clinician and Basic Researchers: Research Focus and How to Raise up Scientific Question

      Dr. LIU Xiaoqing, Chief Physician for the Dept. of Infectious Diseases at Beijing PUMC Hospital

3.     中美药物引起肝损伤(DILI)合作网络模式：上市前/后的药物临床应用安全性

     Building up the Sino-US Collaborative Network on DILI：Pre & Post market Drug Safety and Clinical Applications

      Dr. Paul Watkins, Director of for DILI Program at the Hamner-UNC Institute, North Carolina University

4.     临床研究中试验设计与流行病学方法

     王吉耀教授,上海复旦大学附属中山医院内科主任

     Clinical and Translational Research Practice: Clinical epidemiology and Clinical Trial Design Tools

     Dr. WANG Jiyao, Chief Physician at Zhongshan hospital, Shanghai Fudan University Shanghai Medical College

5.     丙型肝炎与肝癌的临床转化研究依据和临床疗效

     陈德喜教授，首都医科大学附属北京佑安医院,肝病研究所副所长

     Hepatitis C and Liver Cancer: New Drug Translational Research Based on Clinical Therapeutic Evidence

     Dr. CHEN Dexi, Deputy Director for Institute of Liver Disease at Beijing YouAn Hospital, Beijing Capital Med University

6.     题目待定

      茅益民教授, 上海交大医学院附属仁济医院，国家药物临床试验机构（GCP中心）

     Topic TBD

       Dr. Yimin Mao, Shanghai Renji Hospital, GCP Center,  Jiaotong Univ. SOM

7.     肝病的新药物研发思路

     肖小河教授,全军中医药研究所所长, 解放军302医院中西医结合中心

     New Drug Development for Liver Diseases

      Dr. Xiaohe Xiao, Director for PLA TCM Drug Research Institute, PLA 302 Hospital

8.     问答与互动交流（Q & A）

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

晚宴特别会议 (June 22^nd, 18:00 - 20:00):

中美临床和转化医学国际论坛(合作)专家委员会第一次全体会议(Invitation ONLY):

Chaired by Dr. CHEN Zhu, Formerly Minister of Health, China

1．  推选中美临床和转化医学合作专家委员会共同主席、执行委员会成员及秘书长

2．  审议中美临床和转化医学合作建议“2014 -  2018年5年规划”(草案)

3．  讨论中美临床和转化医学项目合作规范和受试者保护机制指南(建议); 拟定在Science杂志正式发表

4．  审议和讨论关于“临床和转化医学基金”项目管理规范和责任,设立管理委员会开展工作

Special Dinner Executive Meeting (June 22^nd, 18:00 - 20:00) (Invitation ONLY):

Chaired by Dr. CHEN Zhu, Formerly Minister of Health, China

Advisory Board Meeting for the Sino-American Collaboration on Clinical and Translational Medicine

1.  Elect Co-chairs, Executive Members and Secretary-in-General for Advisory Board on the Sino-American Collaboration on CTS

2.  Review and Comment on the “2014 - 2018 Five Year Plan” (Draft) for Sino-American Collaboration on CTS projects

3.  Review and Comment on the Principles and Recommendation of Clinical and Translational Research and HRP Program

4.  Review and Comment on “Clinical and Translational Medicine Awards” Governance and the Rules of Law (draft)

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

23日 (星期日)                                  会 议 日 程

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

大会主题3:         奠定临床和转化医学研究的基石:临床和转化研究中的伦理规范和受试者保护机制

Co-Chairs:         Dr. ZENG Yitao and Dr. Robert Califf

8:30-8:55                 演讲8: 转化医学研究的艺术: 科学发展的相通性, 从认知基因到基因相联性疾病的转化研究

                                曾溢滔教授, 上海交通大学遗传疾病研究所所长

                                The Art of Translational Research: Synchronization of Science Development from Gene to Genetic Diseases

                               Dr. ZENG Yitao, Director of Institute of Genetic Diseases, Shanghai Jiaotong University School of Medicine

8:55-9:20                 演讲9: 大学院校/医院－企业－监管机构合作, 整合临床和转化医学科学领域的宝贵资源

                                Dr. Robert Califf, 杜克大学副校长、杜克临床和转化研究院院长

Advancing the Collaborations among Academics, Industrials and Regulatory Agencies: Integration of Valuable

Resources on Clinical and Translational Research

Dr. Robert Califf, Vice Chancellor and Director of Clinical and Translational Sci. Institute, Duke University

9:20-9:45         演讲10: 建立临床人体研究中受试者保护机制 (China-HRPP), 获得国际共识必要性

        Dr. Jeff Cohen, 人体受试者保护咨询机构主任, 前康耐尔大学医学院常务副院长, 主管临床研究

Building up the Human Research Protection Program in Clinical & Translational Research, Gain the Consensus

Dr. Jeff Cohen, Human Research Protections Group, formerly Associate Dean for Cornell Univ. School of Medicine

9:45-10:15                主题论坛三: 转化研究创新推动医学伦理规范和标准的发展

                        Innovation and Translational Research: Bring up the Consensus and Development of Bioethics and Standards  

                        主持人: 时占祥, 全球医生组织执行董事, 中国代表处总代表

Ms. Tesheia Johnson, 耶鲁大学临床转化研究中心执行总监，NIH-CTSA项目管理委员会委员

Dr. Tim Shi, Global MD Organization, Board Director and Chief Representative of Global MD China Office

Ms. Tesheia Johnson, Chief Operating Officer, Yale Center for Clinical Investigation, Yale University, SOM

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

10:15-10:30             茶歇 (Tea/Café break time)

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

大会主题4:         拓展基础与临床转化研究前沿领域与先进技术的合作和交流

Co-Chairs:         Dr. CHENG Jing and Dr. Curt Civin

10:30-10:55             演讲11: 生物芯片技术的前沿发展以及对临床诊疗的指导意义

                                程京教授,清华大学生物芯片中心

                                The Advanced Development on Biochips in Clinical Therapeutics and Diagnosis

                                Dr. CHENG Jing, Tsinghua University and BioCapital Group

10:55-11:20             演讲12: 从基础到临床的转化研究: 采用肿瘤干细胞筛选中医药有效成份和临床试验

                                Dr. Curt I. Civin, 马里兰大学医学院常务副院长, 干细胞研究院院长

                                From Basic to Clinic: Stem Cell Model for Chinese Traditional Medicine and Clinical Trial Studies

                                Dr. Curt I. Civin, Associate Dean for Univ. of Maryland School of Medicine, Director of Stem Cell Res Institute

11:20-11:45             演讲13: 临床和转化医学的关键路径: 关键路径研究院的特殊功能与智库作用

                                Dr. Martha A. Brumfield, 美国关键路径研究院院长

                                What is the Critical Path for Clinical and Translational Medicine in Reality? The Special Roles  of the C-Path

                                Dr. Martha A. Brumfield, CEO of Critical Path Institute, USA

11:45-12:15             特别报告: 中美临床和转化医学国际论坛合作专家委员会: 达成的合作共识与规范 (草案)

                                专家委员会执行主席宣读报告并回答问题

                                Special Report:

                                Sino-American Collaboration on Clinical and Translational Medicine: Consensus and Recommendation (draft)

                               By the elected chair of the Advisory Committee

12:15-12:30              大会主席总结：新起点、新目标和预期未来

Ramp-Up Summary: New Starting-up, New Target and Perspectives in the Near Future

By co- chairs of the SAS-CTM

12:30               休会 Adjacent

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

下午:           合作意向交流—潜在合作伙伴

12:45-14:00          交流午餐 (自理)

14:00-15:30          寻找自己理想中的合作伙伴和共同创业者

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------